Global Infectious Disease Diagnostics Market Growth (Status and Outlook) 2023-2029

Global Infectious Disease Diagnostics Market Growth (Status and Outlook) 2023-2029

Infectious-disease diagnostics is the procedure by which the causative agent of an infectious disease is identified and often characterized.

LPI (LP Information)' newest research report, the “Infectious Disease Diagnostics Industry Forecast” looks at past sales and reviews total world Infectious Disease Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Infectious Disease Diagnostics sales for 2023 through 2029. With Infectious Disease Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Infectious Disease Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Infectious Disease Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Infectious Disease Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Infectious Disease Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Infectious Disease Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Infectious Disease Diagnostics.

The global Infectious Disease Diagnostics market size is projected to grow from US$ 3564.7 million in 2022 to US$ 4838.4 million in 2029; it is expected to grow at a CAGR of 4.5% from 2023 to 2029.

United States market for Infectious Disease Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Infectious Disease Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Infectious Disease Diagnostics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Infectious Disease Diagnostics players cover Bio Mérieux SA, Roche Diagnostics, Abbott Laboratories, Thermo Fischer Scientific, BD, Bio-Rad Laboratories, Abbott, Danaher and Johnson and Johnson, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Infectious Disease Diagnostics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Molecular Diagnostic Technique
Traditional Diagnostic Technique

Segmentation by application
Hepatitis C
Hepatitis B
Tuberculosis (TB)
Acquired Immunodeficiency Syndrome (AIDS)
Human Papillomavirus (HPV)
Methicillin-resistant Staphylococcus Aureus (MRSA)

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Bio Mérieux SA
Roche Diagnostics
Abbott Laboratories
Thermo Fischer Scientific
BD
Bio-Rad Laboratories
Abbott
Danaher
Johnson and Johnson
Guangzhou Wondfo Biotech Co.,Ltd.
Getein Biotech, Inc.
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
BGI Genomics Co.,Ltd.
Maccura Biotechnology Co.,Ltd.
Daan Gene
Beijing Strong Biotechnologies,Inc
Shanghai Kehua Bio-Engineering Co.,Ltd.
Guangdong Hybribio Biotech Co.,Ltd.
Shanghai Runda Medical Technology Co.,Ltd.
Tellgen Corporation

Please note: The report will take approximately 2 business days to prepare and deliver.